Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
KillaKwinn Fund (KKF) is an emerging micro-venture capital fund founded by Dr. Quinn Wang, a cataract surgeon trained at Duke University and the University of California, San Francisco. The fund is dedicated to supporting underestimated founders, particularly in the bio/health, deeptech, and fintech sectors. KKF aims to address significant challenges in these industries by investing at the pre-seed and seed stages.
Dr. Wang's background in healthcare entrepreneurship informs the fund's investment strategy, allowing him to identify and nurture innovative solutions. Although specific details about the fund's size, portfolio, and team are currently unavailable due to the inactive status of its website, KKF is recognized as part of the Sydecar fellow program, which supports emerging fund managers.
KillaKwinn Fund focuses on investing in early-stage companies that tackle pressing issues in healthcare and technology. The fund specifically targets underestimated founders who may lack traditional backing but possess the vision and capability to drive impactful change. KKF's investment strategy encompasses sectors such as bio/health, deeptech, and fintech, reflecting a commitment to addressing significant challenges in these fields.
Investments are primarily made at the pre-seed and seed stages, allowing KKF to engage with startups at their inception. The fund seeks to provide not only capital but also strategic guidance and support, leveraging Dr. Wang's expertise in healthcare and technology to foster growth and innovation within its portfolio companies.
Quinn Wang, MD - Founder
Dr. Quinn Wang is a Duke and UCSF-trained cataract surgeon and a VC-backed entrepreneur. He founded Quadrant Eye, a healthcare startup focused on developing remote eye testing solutions to prevent preventable blindness. Wang's experience in healthcare entrepreneurship informs his investment strategy at KillaKwinn Fund.
No recent activity has been reported for KillaKwinn Fund, as the website is currently inactive. This suggests a pause in operations or outreach.
What are KillaKwinn Fund's investment criteria?
KKF invests in early-stage companies, particularly at the pre-seed and seed stages, focusing on underestimated founders in the bio/health, deeptech, and fintech sectors.
How can founders apply or pitch to KillaKwinn Fund?
Currently, there is no publicly available contact information or application portal due to the inactive status of the KKF website. Founders may need to seek alternative channels to connect with the fund.
What makes KillaKwinn Fund different from other micro-VCs?
KKF's unique focus on supporting underestimated founders sets it apart from other micro-VCs. The fund leverages Dr. Wang's healthcare background to inform its investment strategy and provide valuable insights to portfolio companies.
What is the geographic scope of KillaKwinn Fund's investments?
While specific geographic focus details are not available, KKF's emphasis on healthcare and technology suggests a potential interest in regions with strong innovation ecosystems in these sectors.
What is the fund size and check size for KillaKwinn Fund?
Details regarding the fund size and check sizes are currently undisclosed. However, as an emerging manager, KKF is likely to operate as a micro-fund.
What type of post-investment involvement does KillaKwinn Fund have?
KKF provides strategic guidance and support to its portfolio companies, leveraging Dr. Wang's expertise to foster growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.